Clinical manifestations of the skin photodamage as a result of a multi-course phototherapy of psoriasis patients
- 作者: Zhilova M.B.1, Volnukhin V.A.1, Dvornikov A.S.2
-
隶属关系:
- State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
- The Russian National Research Medical University named after N.I. Pirogov (RNRMU)
- 期: 卷 90, 编号 6 (2014)
- 页面: 114-120
- 栏目: CLINICAL PRACTICE GUIDELINES
- URL: https://ogarev-online.ru/0042-4609/article/view/116691
- DOI: https://doi.org/10.25208/0042-4609-2014-90-6-114-120
- ID: 116691
如何引用文章
全文:
详细
作者简介
M. Zhilova
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
编辑信件的主要联系方式.
Email: zhilova@cnikvi.ru
俄罗斯联邦
V. Volnukhin
State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation
Email: noemail@neicon.ru
俄罗斯联邦
A. Dvornikov
The Russian National Research Medical University named after N.I. Pirogov (RNRMU)
Email: noemail@neicon.ru
俄罗斯联邦
参考
- Дерматология Фицпатрика в клинической практике: в 3 т. Клаус Вольф, Лоуэлл А. Голдсмит, Стивен И. Кац, Барбара А. Джилкрест, Эми С. Паллер, Дэвид Дж. Леффель // Под ред. акад. А.А. Кубановой. М.: Издательство Панфилова; БИНОМ. Лаборатория знаний 2012; 1: 180-207
- Wolff K. Side-effects of psoralen photochemotherapy (PUVA). Br J Dermatol 1990; 122: 117-125.
- Stern R.S., Nichols K.T., Vakeva L.H. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997; 336: 1041-1045.
- Lindelöf B., Sigurgeirsson B., Tegner E. et al. PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 1999; 141: 108-112.
- Stern R.S.; PUVA Follow-Up Study. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012; 66 (4): 553-562.
- Archier E., Devaux S., Castela E. et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012; 26 Suppl 3: 22-31.
- Смирнова И.О. Функциональная морфология старения кожи. Успехи геронтологии 2004; 13: 44-51
- Matsumura Y., Ananthaswamy H.N. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004; 195 (3): 298-308.
- Rhodes A.R., Stern R.S., Melski J.W. The PUVA lentigo: an analysis of predisposing factors. J Invest Dermatol 1983; 81: 459-463.
- Ros A.M., Wennersten G., Lagerholm B. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions. Acta Derm Venereol 1983; 63 (3): 215-221.
- Cox N.H., Jones S.K., Downey D.J. et al. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Br J Dermatol 1987; 116 (2): 145-152.
- Abdullah A.N., Keczkes K. Cutaneous and ocular side-effects of PUVA photochemotherapy-a 10-year follow-up study. Clin Exp Dermatol. 1989; 14 (6): 421-424.
- Stern R.S. Actinic degeneration and pigmentary change in association with psoralen and UVA treatment: a 20-year prospective study. J Am Acad Dermatol 2003; 48: 61-67.
- Nakagawa H., Rhodes A.R., Momtaz T.K. et al. Melanosomal alterations in PUVA lentigines (Abstr). J Invest Dermatol 1983; 80: 378.
- Gschnait F., Wolff K., Hönigsmann H. et al. Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients. Br J Dermatol 1980; 103 (1): 11-22.
- Hönigsmann H., Wolff K., Gschnait F., Brenner W., Jaschke E. Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA). J Am Acad Dermatol 1980; 3 (4): 406-414.
- Abel E.A., Cox A.J., Farber E.M. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study. J Am Acad Dermatol. 1982; 7 (3): 333-340.
- van Praag M.C., Bavinck J.N., Bergman W. et al. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer. J Am Acad Dermatol 1993; 28 (3): 412-417.
- Lever L.R., Farr P.M. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994; 131 (2): 215-219.
- Олисова О.Ю., Владимиров В.В., Лукашева Н.Н., Пушкина М.Ю., Смирнов К.В. Отдаленные результаты ПУВА-терапии дерматозов (обзор литературы). Росс журн кожн вен бол 2005; 1: 30-33
补充文件
